{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-314167","form_type":"8-K","ticker":"IMA","cik":"0001835579","company_name":"ImageneBio, Inc.","filed_at":"2026-07-23T20:25:51+00:00","discovered_at":"2026-07-23T20:27:00.415062+00:00","generated_at":"2026-07-23T20:27:10.244034+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ImageneBio appoints Yanina Grant-Huerta as CFO; CMO Benjamin Porter-Brown transitions to consulting role","bullets":["Yanina Grant-Huerta appointed CFO effective July 20, 2026; base salary $450,000, target bonus 40%, equity grants of 65,000 RSUs and 95,000 options.","Benjamin Porter-Brown, CMO, will transition from full-time to consulting role effective July 24, 2026; will serve as strategic advisor.","Grant-Huerta previously served as Chief Accounting Officer at Atara Biotherapeutics (ATRA) from March 2025 to July 2026.","Grant-Huerta's equity awards vest over four years; 25% on first anniversary, remainder monthly/quarterly."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-314167","json":"https://secwatch.observer/filing/0001193125-26-314167.json","markdown":"https://secwatch.observer/filing/0001193125-26-314167.md","text":"https://secwatch.observer/filing/0001193125-26-314167.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835579/000119312526314167/0001193125-26-314167-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835579/000119312526314167/d143178d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-23T20:27:10.244034+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"600e0fff0e","claim":"Yanina Grant-Huerta was appointed as Chief Financial Officer at ImageneBio, Inc..","evidence_excerpt":"On July 20, 2026, ImageneBio, Inc., a Delaware corporation (the “Company”), based in part on the recommendation of Kristin Yarema, Ph.D., the Company’s Chief Executive Officer, appointed Yanina Grant-Huerta as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective July 20, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835579/000119312526314167/0001193125-26-314167-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}